Sibel Health awarded a major grant to advance maternal monitoring solution for low-and-middle income countries.
Summary
Grant support from the Bill & Melinda Gates Foundation will extend Sibel Healths AI-enabled, and FDA-cleared ANNE\xae One monitoring solution to improve maternal health monitoring globally Sibel Health partners with the and the National Institute for Health and Care Research (NIHR) Global Health Research Unit on Global Surgery (Global Surgery Unit) to develop solutions in collaboration with leading Indian, Pakistani, and Nigerian institutes.CHICAGO, April 23, 2024 /PRNewswire/ -- Sibel Health, an award-winning health technology company backed by the Steele Foundation for Hope, announced it has received a $17.5 million dollar grant from the Bill & Melinda Gates Foundation to advance the use of its FDA-cleared wireless monitoring solution, ANNE\xae One, for labor triage and continuous maternal health monitoring in low-and-middle income countries (LMICs) to reduce obstetrical morbidity and mortality. With more than 12,000 pregnancies monitored in LMICs already, Sibel Health is positioned to develop new purpose-built products in partnership with the University of Edinburgh and the NIHR Global Surgery Unit. The ANNE\xae One platform is an FDA-cleared platform capable of monitoring all vital signs in home and hospital settings for patients 12 years and older powered by AI-enabled advanced wearable sensors. It is Sibels 4th FDA clearance since 2021.